[Bacteremia by Escherichia coli resistant to amoxycillin/clavulanic acid, ampicillin/sulbactam and piperacillin/tazobactam].
Alós
J I
JI
Gómez-Garcés
J L
JL
Mateos
M V
MV
D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D013407:Sulbactam / Q000627:therapeutic use; D000078142:Tazobactam
D002969:Clavulanic Acids; D019818:Clavulanic Acid; D000667:Ampicillin; D010397:Penicillanic Acid; D013407:Sulbactam; D000078142:Tazobactam
Bacteriemia por Escherichia coli resistente a amoxicilina/ácido clavulánico, ampicilina/sulbactam y piperacilina/tazobactam.